Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Q and A with CEO

    Building an innovation-powered economy

    China Daily | Updated: 2019-03-21 10:10
    Share
    Share - WeChat
    Will Song, chairman of Johnson & Johnson China. [Photo provided to China Daily]

    A1 China's most significant achievement has been the profound development in people's health and livelihoods. China is becoming a leader in global healthcare and the government is reforming pharmaceutical innovation to allow patients greater access to cutting-edge treatments.

    Johnson & Johnson entered the Chinese mainland in 1985 with the opening of Xi'an Janssen - one of the first joint venture pharmaceutical companies in China. We now have 16 legal entities in China, eight production bases across all our three business sectors - pharmaceutics, medical devices and consumer with more than 10,000 people in 90 cities.

    A2 As a leading healthcare company, we are delighted to see the Chinese government promote high-quality growth. Driving high-quality growth is also the strategy that Johnson & Johnson has fostered in China. We are continuously introducing innovative products and technologies as well as strengthening our own R&D capabilities in China.

    A3 The legislation on foreign investment demonstrates China's determination to expand its opening to the outside world and create a more open, fair and transparent investment environment. We are glad to see that the law clearly states that multinational corporations will be treated equally and we hope that mandatory standards will be reduced to encourage product innovation. The law will allow us to protect our latest treatments, and we warmly welcome the government's efforts to open the economy and give Chinese patients new ways of receiving vital care.

    A4 We strongly support the government's "Healthy China 2030" plan to deliver accessible and comprehensive care and are continuing to introduce the most advanced treatments as well as grow the healthcare ecosystem to reinforce these aims.

    In 2018, all our business sectors yielded extraordinary results in China. These won't be possible without the favorable government policies to speed up the approval process for drugs and medical devices, the fast-changing consumption upgrade landscape, and most importantly, our dedication and commitment to addressing the unmet needs of our patients and consumers in China.

    A5 The government's strong efforts to enhance efficiency in the healthcare sector over the last two years have been transformative. We applaud the numerous positive steps to exclude cancer medicines from tariffs; reduce the price of cancer treatments; incorporate innovative imported drugs, especially much-needed cancer treatments, into the catalog of medical insurance reimbursement; and accelerate national reimbursement drug list approval for innovative therapies.

    |<< Previous 1 2 3 4 5 6 7   
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    伊人久久无码精品中文字幕| 亚洲av永久无码精品漫画 | 少妇性饥渴无码A区免费| 国内精品人妻无码久久久影院| 中文字幕在线观看| 亚洲av无码乱码在线观看野外| 亚洲日韩精品A∨片无码| 无码内射中文字幕岛国片| 本道天堂成在人线av无码免费| av无码人妻一区二区三区牛牛| 天堂中文在线资源| 狠狠精品久久久无码中文字幕| av一区二区人妻无码| 日日摸日日踫夜夜爽无码| 国产AV无码专区亚洲AV漫画| 视频二区中文字幕| 成人精品一区二区三区中文字幕| 亚洲Av无码乱码在线观看性色 | 精品无码人妻一区二区三区品| 无码国产精品一区二区免费式直播 | 狠狠精品干练久久久无码中文字幕 | 777久久精品一区二区三区无码 | 无码国产精品一区二区免费式直播 | 最近中文国语字幕在线播放| 韩国中文字幕毛片| 最新中文字幕AV无码不卡| 久久国产三级无码一区二区| 99久久国产热无码精品免费| 无码国产精品一区二区免费vr| 亚洲国产综合无码一区| 国产色综合久久无码有码| 无码人妻精品一区二区蜜桃网站| 日本欧美亚洲中文| 人妻少妇无码精品视频区 | 中文字幕日韩理论在线| 亚洲福利中文字幕在线网址| 91天日语中文字幕在线观看 | 性无码专区| 一区二区三区无码高清| 少妇人妻88久久中文字幕| 国产成人三级经典中文|